Coronary epicardic vasospasm in patient treated with desatinib for lymphoblastic leukaemia: the other side of the medal

Eur Heart J. 2019 Apr 14;40(15):1235. doi: 10.1093/eurheartj/ehz054.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Coronary Angiography / methods
  • Coronary Vasospasm / chemically induced*
  • Coronary Vasospasm / diagnostic imaging
  • Coronary Vasospasm / drug therapy
  • Dasatinib / adverse effects*
  • Dasatinib / therapeutic use
  • Electrocardiography / methods
  • Humans
  • Male
  • Nitroglycerin / administration & dosage
  • Nitroglycerin / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • ST Elevation Myocardial Infarction / physiopathology
  • Treatment Outcome
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use

Substances

  • Protein Kinase Inhibitors
  • Vasodilator Agents
  • Nitroglycerin
  • Dasatinib